Business services providers thrive by solving complex operational challenges for their clients, allowing them to focus on ...

Equifax® (NYSE: EFX) today announced that the Equifax Board of Directors declared a quarterly dividend of $0.50 per share, payable on September 15, 2025, to shareholders of record as of the close of ...

Equifax faces growth headwinds, premium valuation, and flat price action despite AI and cloud investments, with limited ...

Results support potential of efruxifermin (EFX) to reduce risk of fibrosis progression in patients with pre-cirrhotic (F2-F3) MASH ...

Let's take a closer look.Everyone has their own methods for finding great value opportunities, but our model includes pairing an impressive grade in the Value category of our Style Scores system with ...

The case involved a clinical trial of Akero's only product, a drug candidate aimed at treating a liver disease. It's the ...

Albertans are missing credit payments at one of the highest rates in the country, as Equifax Canada warns of a widening ...

Have you assessed how the international operations of Equifax (EFX) performed in the quarter ended June 2025? For this credit reporting company, possessing an expansive global footprint, parsing the ...

Published results from the 96-Week Phase 2b SYMMETRY trial in the New England Journal of MedicineThree presentations at the ...

Shares of Equifax Inc. EFX slid 2.06% to $248.07 Thursday, on what proved to be an all-around mixed trading session for the ...

A new Equifax Canada report shows 1.4 million Canadians missed a credit payment in the second quarter. While that’s up by 118 ...

Published results from the 96-Week Phase 2b SYMMETRY trial in the New England Journal of Medicine Three presentations at the EASL Congress 2025 highlighted data demonstrating statistically significant ...